Zhibin Liu at Kyungpook National University, South Korea
Professional Profile
Summary
Dr. Zhibin Liu is an emerging biomedical researcher affiliated with Kyungpook National University, South Korea. With a strong background in dental hygiene and biomedical sciences, his interdisciplinary work focuses on cancer biology, antibacterial therapies, and molecular toxicology. His collaborative research efforts have led to several impactful publications in peer-reviewed journals, where he explores cellular mechanisms, therapeutic compounds, and environmental health risks, contributing to both academic and translational science.
Educational Details
Dr. Liu began his academic journey at Kyungpook National University, where he completed his undergraduate studies in Dental Hygiene from 2017 to 2021. He continued with a master's program in the same field, graduating in 2023. He is currently pursuing advanced research (since September 2023) at the university in the domain of development and differentiation regulation, positioning himself at the intersection of dental science and molecular biology.
Professional Experience
Dr. Liu’s professional and academic training is rooted in laboratory-based research, where he has contributed to multiple interdisciplinary projects under renowned mentors. He has collaborated across departments and institutions on experimental studies related to oncology, microbiology, and pharmacology. His hands-on involvement in animal studies, in vitro analysis, and data interpretation reflects a strong experimental and collaborative orientation.
Research Interests
Dr. Liu’s research interests span cancer therapeutics, oral microbiology, wound healing, and environmental toxicology. He investigates the molecular pathways involved in esophageal and oral squamous cell carcinomas, including the AKT/mTOR and PI3K signaling axes. He is also deeply engaged in evaluating natural compounds, hydrogen-rich water, and nanoparticles for their antibacterial and anticancer properties. His work integrates biochemical analysis with clinical relevance, aiming to bridge lab findings with practical healthcare applications.
Author Metrics
Dr. Liu has co-authored several high-impact publications across journals such as Antioxidants, Scientific Reports, Pharmaceuticals, Journal of Cancer, and In Vivo. His work is frequently cited in the domains of molecular oncology, oral science, and immunology, and he maintains a growing academic presence on platforms like ResearchGate, Google Scholar, and PubMed. These publications showcase his proficiency in experimental design and scientific communication.
Awards and Honors
Dr. Liu has been recognized for his academic and research excellence by Kyungpook National University. He received the Fusion Research Group Award in 2022, acknowledging his multidisciplinary contributions. In 2021, he was honored as an Honorary International Ambassador, reflecting his role in promoting the university’s global academic engagement. These accolades highlight his dedication to collaborative science and leadership potential in research communities.
Publicaiton Top Notes
1. Raepenol™ Cream, a Complex of Natural Compounds, Promotes Wound Healing and Relieves Pruritus In Vivo
Authors: Kim E, Cho NE, Park S, Kim HG, Yi J, Kim H, Ma L, Huang KE, Liu Z, Kim CY, Park K, Sung Y, Jang S, Jang S, Choi SK, Ryoo ZY, Lim SG, Kim MO
Journal: In Vivo, 2024 Sep–Oct; 38(5):2318–2327
Summary:
This study investigates Raepenol™ Cream, a proprietary formulation made from natural compounds, and its therapeutic effects on wound healing and itch relief (pruritus). Conducted using in vivo models, the research demonstrates that the cream accelerates epidermal regeneration and reduces inflammatory cytokine expression. Dr. Liu contributed to evaluating histopathological changes and analyzing inflammation markers in treated tissues.
2. Gossypetin Alleviates DSS-Induced Colitis by Regulating COX2 and ROS-JNK Signaling
Authors: Kim H, Kim E, Ma L, Kim C, Park K, Liu Z, Huang K, Kim DJ, Ryoo ZY, Yi JK, Sung Y, Jang S, Kim MO
Journal: Current Pharmaceutical Biotechnology, 2024 Nov 26
Summary:
This study explores the anti-inflammatory properties of gossypetin, a flavonoid derived from Hibiscus sabdariffa, in dextran sulfate sodium (DSS)-induced colitis mouse models. It was found that gossypetin reduced colonic damage, COX2 expression, and ROS-JNK pathway activity, suggesting potential therapeutic utility in inflammatory bowel disease (IBD). Dr. Liu contributed to the experimental design and molecular assays related to oxidative stress and inflammation.
3. Effects of PM2.5 Metal Components Derived From Porcine Farm Exposure on Sperm Function in Mice
Authors: Kim C. Y., Kim C. R., Kim E., Park K., Kim H., Ma L., Huang K., Liu Z., Park J., Jung M., Li S., Wen W., Kim S., Park S., Ryoo Z. Y., Yi J., Kim M. O
Journal: Journal of Biochemical and Molecular Toxicology, 2025; 39(5):e70279
Summary:
This paper assesses the impact of PM2.5 metal pollutants from porcine farm environments on male reproductive health. The findings revealed disruption in sperm motility and function, likely due to heavy metal-induced oxidative stress. Dr. Liu’s role involved data collection on sperm morphology and analysis of oxidative damage biomarkers, contributing to understanding environmental toxicity and reproductive risks.
4. Effects of the Major Metal Components in Urban Asian PM2.5 on Lung Inflammation and Abnormal Electrolyte Levels: An In Vivo Study Based on Review Data
Authors: Kim E, Huang K, Yi J, Ma L, Kim C. Y., Park K, Liu Z., et al.
Journal: Environmental Pollutants and Bioavailability, 2024; 36(1):2396464
Summary:
This study examines how urban PM2.5 metal constituents contribute to pulmonary inflammation and electrolyte imbalance in animal models. Results highlight elevated pro-inflammatory cytokines and disrupted sodium/potassium regulation in the lungs following exposure. Dr. Liu supported the animal model analysis and electrolyte quantification, aiding in uncovering public health implications of air pollution.
5. Evaluation of Zinc Oxide and Copper Oxide Nanoparticles as Potential Alternatives to Antibiotics for Managing Fowl Typhoid in Broilers
Authors: Raza M.A., Kim E., Shakeel M., Fiaz M., Ma L., Kim H., Kim C. Y., Liu Z., Huang K., Park K., Javed M.T., Kim M.O
Journal: Journal of Animal Science and Technology, 2024; 66(5):962–980
Summary:
This publication presents an antimicrobial assessment of ZnO and CuO nanoparticles against Salmonella gallinarum in poultry. The study reports reduced bacterial load, mortality, and improved gut health with nanoparticle treatment, offering an alternative to conventional antibiotics. Dr. Liu contributed to microbial assays and tissue analysis, reinforcing his involvement in nanotechnology-based infection control.
Conclusion
Dr. Zhibin Liu is a promising young biomedical scientist who blends technical skill, interdisciplinary breadth, and scientific curiosity. His contributions to molecular cancer biology, toxicological research, and natural compound therapeutics reflect strong academic potential and research maturity. While there is room to grow in terms of scientific leadership and narrowed specialization, his trajectory is undoubtedly rising.